SCHEDULE 13G/A
Statement of Beneficial Ownership
Stoke Therapeutics, Inc. Filed Acc 0000895421-26-000321
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Morgan Stanley | 3,177,169 | 4.9% |
| Morgan Stanley Capital Services LLC | 2,653,126 | 4.1% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Loading xslSCHEDULE_13G_X02/primary_doc.xml…